What BD Selling Its Diagnostics Business Could Mean for Clinical Labs
Scott Wallask, BA
Becton Dickinson’s plans will shift the IVD market and possibly create a stronger contender
New joint consensus manuscript from AMP developed in collaboration with ASCO and CAP